J&J Collaboration for Autologous CAR-T

About Cellular Origins

Cellular Origins is a private, pre-revenue platform company addressing the acute scalability challenge in cell and gene therapy (CGT) manufacturing through its Constellation robotic automation ecosystem. The platform's key differentiator is its flexibility, allowing therapy developers to automate their existing, proven processes without significant re-engineering, thereby reducing labor dependency and facility footprint while improving consistency and quality. Backed by a recent $40M Series A and strategic collaborations with industry leaders like Johnson & Johnson and Fresenius Kabi, the company is positioned as a key enabler for the industrialisation of the CGT sector.

Therapeutic Areas